(Q34553838)

3 August 2017

1 reference

title

Cholesterol, A beta and Alzheimer's disease (English)

1 reference

3 August 2017

0 references

Hartmann T

1

1 reference

3 August 2017

publication date

1 November 2001

1 reference

3 August 2017

published in

Trends in Neurosciences

1 reference

3 August 2017

volume

24

1 reference

3 August 2017

issue

11 Suppl

1 reference

3 August 2017

page(s)

S45-8

1 reference

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Evidence that Aβ42 is the real culprit in alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Apolipoprotein E: far more than a lipid transport protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Current perspectives on statins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Use of statins in CNS disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

The role of cholesterol in the biosynthesis of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Cellular cholesterol efflux mediated by cyclodextrins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Alzheimer's disease: beta-amyloid hypothesis strengthened!

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Cholesterol metabolism in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901990-1

7 January 2021

10.1016/S0166-2236(00)01990-1

Identifiers

DOI

1 reference

3 August 2017

1 reference